- Boston Scientific appoints Jon Monson as the new CFO, set to take over on June 30.
- Wall Street analysts project a 22.40% upside for Boston Scientific’s stock price.
- Despite an "Outperform" status, GuruFocus projects a 19.05% downside based on GF Value.
Boston Scientific Corp. (BSX), a leading player in the medical devices industry, has announced a significant leadership change. Long-time Chief Financial Officer and Executive Vice President Dan Brennan will be retiring after an impressive tenure of over a decade. The company's current Senior Vice President of Investor Relations, Jon Monson, is set to assume the role of CFO on June 30. Brennan will continue to lend his expertise as a senior advisor until October 2025, ensuring a smooth transition.
Wall Street Analysts Forecast
With a keen eye on Boston Scientific's trajectory, 30 analysts have provided one-year price targets for the company. The average target price stands at $116.34, with forecasts spanning from a high of $130.00 to a low of $84.11. This suggests a potential upside of 22.40% from the current trading price of $95.05. For further insights, visit the Boston Scientific Corp (BSX, Financial) Forecast page.
In terms of overall sentiment, 34 brokerage firms have weighed in, collectively awarding Boston Scientific an average recommendation score of 1.8. This positions the stock at an "Outperform" status on a scale where 1 signifies a Strong Buy and 5 indicates a Sell.
GuruFocus Valuation
Despite the optimistic outlook from Wall Street, GuruFocus offers a more conservative estimate. The anticipated GF Value of Boston Scientific in one year is projected at $76.94. This valuation reflects a potential downside of 19.05% from the current price point. The GF Value represents GuruFocus's assessment of the fair value the stock should trade at, calculated by examining historical trading multiples, past growth, and future performance estimates. For a deeper dive into these metrics, visit the Boston Scientific Corp (BSX, Financial) Summary page.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
